COBRE

Axel Lehrer, Ph.D.

Assistant Professor
Department of Tropical Medicine, Medical Microbiology and Pharmacology
John A. Burns School of Medicine

Phone:
Office: BSB 320B
Email: lehrer [at] hawaii.edu


1998	M.Sc.	(Biochemistry) University of Bayreuth, Germany
2001	Ph.D.	(Biology) University of Bayreuth, Germany

Vaccinology, Molecular Virology


2011-present	American Society of Microbiology
2002-present	American Society for Biochemistry and Molecular Biology
2004-2010	American Society for Tropical Medicine and Hygiene

Research Keywords: Ebola, filoviruses

Haun BK, Kamara V, Dweh AS, Garalde-Machida K, Forkay SSE, Takaaze M, Namekar M, Wong TAS, Bell-Gam Woto AER, Humphreys P, Weeks OI, Fallah MP, Berestecky JM, Nerurkar VR, Lehrer AT.
Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: a preliminary report.
PLoS Neglected Tropical Diseases 2019 more details...
Medina LO, To A, Lieberman MM, Wong TAS, Namekar M, Nakano E, Andersen H, Yalley-Ogunro J, Greenhouse J, Higgs S, Huang YS, Vanlandingham DL, Horton JS, Clements DE, Lehrer AT.
A recombinant subunit based Zika virus vaccine is efficacious in non-human primates.
Frontiers in Immunology 2018 more details...
To A, Medina LO, Mfuh KO, Lieberman MM, Wong TAS, Namekar M, Nakano E, Lai CY, Kumar M, Nerurkar VR, Lehrer AT.
Recombinant Zika virus subunits are immunogenic and efficacious in mice.
mSphere 2018 more details...
Lai C-Y, Strange DP, Wong TAS, Lehrer AT, Verma S.
Ebola virus glycoprotein induces an innate immune response in vivo via TLR4.
Frontiers in Microbiology 2017 more details...
Lehrer AT, Wong TS, Lieberman MM, Humphreys T, Clements DE, Bakken RR, Hart MK, Pratt WD, Dye JM.
Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.
Vaccine 2017 more details...

Grant No / Title: 1 U01GH002256-01 / Epidemiology and Immunity to Ebola Virus and Other Emerging Viral Infections in Liberia
Status / Agency: Awarded / Centers for Disease Control
Start Date / End Date: 30 September 2019 / 29 September 2024
Grant No / Title: R01AI132323 / Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
Status / Agency: Awarded / NIH/NIAID
Start Date / End Date: 20 June 2017 / 31 May 2022
Grant No / Title: R01AI119185 / Defining a Protective Ebola Vaccine in Non-human Primates
Status / Agency: Awarded / NIH/NIAID
Start Date / End Date: 28 August 2015 / 31 July 2019
Grant No / Title: W81XWH-15-R-0015 / US Army Medical Research Institute of Infectious Diseases (USAMRIID) Requirement to Develop, Produce and Deploy MAGPIX-Based Immunoassays
Status / Agency: Awarded / Department of Defense, U.S. Army Medical Research Acquisitions Administration
Start Date / End Date: 13 July 2015 / 12 July 2017